The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST)
.If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Expression of IL-4 by stimulated CD4+ and CD4-BALB/c spleen cells. BALB/c spleen cells were cultured for 72 h in medium containing Staphylococcus aureus enterotoxin B (2 µg/ml; Sigma, St. Louis, MO), recombinant mouse IL-2 (10 U/ml, Cat. No. 550069) and recombinant mouse IL-4 (2 ng/ml, Cat. No. 550067). The cells were harvested and restimulated for 5 h with anti-CD3 (145-2C11, Cat. No. 553057 at 2 µg/ml) and anti-CD28 (clone 37.51, Cat. No. 553294 at 2 µg/ml) antibodies in the presence of 3 µM monensin (BD GolgiStop, Cat No. 554704). The splenocytes were then stained with 0.25 µg of FITC-conjugated rat anti-mouse CD4 (FITC-RM4-5, Cat. No. 553047) and 0.25 µg of PE-conjugated rat anti-mouse IL-4 antibody (PE11B11, Cat. No 554435) by using the Pharmingen staining protocol (left panel). To demonstrate staining specificity, the binding of PE-11B11 was blocked by the preincubation of the conjugated antibody with excess recombinant mouse IL-4 (0.25 µg; Cat. No. 550067) (right panel) or by pre-blocking fixed/permeabilized cells with excess purified 11B11 mAb (5.0 µg; Cat. No. 554433) (data not shown), prior to staining. An approprate isotype control is PE-conjugated R3-34, (Cat. No. 554685). The quadrant markers for the bivariate dot plots were set based on the autofluorescence control, and verified using the cytokine-blocking or mAb blocking controls.
Expression of IL-4 by stimulated CD4+ and CD4-BALB/c spleen cells. BALB/c spleen cells were cultured for 72 h in medium containing Staphylococcus aureus enterotoxin B (2 µg/ml; Sigma, St. Louis, MO), recombinant mouse IL-2 (10 U/ml, Cat. No. 550069) and recombinant mouse IL-4 (2 ng/ml, Cat. No. 550067). The cells were harvested and restimulated for 5 h with anti-CD3 (145-2C11, Cat. No. 553057 at 2 µg/ml) and anti-CD28 (clone 37.51, Cat. No. 553294 at 2 µg/ml) antibodies in the presence of 3 µM monensin (BD GolgiStop, Cat No. 554704). The splenocytes were then stained with 0.25 µg of FITC-conjugated rat anti-mouse CD4 (FITC-RM4-5, Cat. No. 553047) and 0.25 µg of PE-conjugated rat anti-mouse IL-4 antibody (PE11B11, Cat. No 554435) by using the Pharmingen staining protocol (left panel). To demonstrate staining specificity, the binding of PE-11B11 was blocked by the preincubation of the conjugated antibody with excess recombinant mouse IL-4 (0.25 µg; Cat. No. 550067) (right panel) or by pre-blocking fixed/permeabilized cells with excess purified 11B11 mAb (5.0 µg; Cat. No. 554433) (data not shown), prior to staining. An approprate isotype control is PE-conjugated R3-34, (Cat. No. 554685). The quadrant markers for the bivariate dot plots were set based on the autofluorescence control, and verified using the cytokine-blocking or mAb blocking controls.
Expression of IL-4 by stimulated CD4+ and CD4-BALB/c spleen cells. BALB/c spleen cells were cultured for 72 h in medium containing Staphylococcus aureus enterotoxin B (2 µg/ml; Sigma, St. Louis, MO), recombinant mouse IL-2 (10 U/ml, Cat. No. 550069) and recombinant mouse IL-4 (2 ng/ml, Cat. No. 550067). The cells were harvested and restimulated for 5 h with anti-CD3 (145-2C11, Cat. No. 553057 at 2 µg/ml) and anti-CD28 (clone 37.51, Cat. No. 553294 at 2 µg/ml) antibodies in the presence of 3 µM monensin (BD GolgiStop, Cat No. 554704). The splenocytes were then stained with 0.25 µg of FITC-conjugated rat anti-mouse CD4 (FITC-RM4-5, Cat. No. 553047) and 0.25 µg of PE-conjugated rat anti-mouse IL-4 antibody (PE11B11, Cat. No 554435) by using the Pharmingen staining protocol (left panel). To demonstrate staining specificity, the binding of PE-11B11 was blocked by the preincubation of the conjugated antibody with excess recombinant mouse IL-4 (0.25 µg; Cat. No. 550067) (right panel) or by pre-blocking fixed/permeabilized cells with excess purified 11B11 mAb (5.0 µg; Cat. No. 554433) (data not shown), prior to staining. An approprate isotype control is PE-conjugated R3-34, (Cat. No. 554685). The quadrant markers for the bivariate dot plots were set based on the autofluorescence control, and verified using the cytokine-blocking or mAb blocking controls.
Expression of IL-4 by stimulated CD4+ and CD4-BALB/c spleen cells. BALB/c spleen cells were cultured for 72 h in medium containing Staphylococcus aureus enterotoxin B (2 µg/ml; Sigma, St. Louis, MO), recombinant mouse IL-2 (10 U/ml, Cat. No. 550069) and recombinant mouse IL-4 (2 ng/ml, Cat. No. 550067). The cells were harvested and restimulated for 5 h with anti-CD3 (145-2C11, Cat. No. 553057 at 2 µg/ml) and anti-CD28 (clone 37.51, Cat. No. 553294 at 2 µg/ml) antibodies in the presence of 3 µM monensin (BD GolgiStop, Cat No. 554704). The splenocytes were then stained with 0.25 µg of FITC-conjugated rat anti-mouse CD4 (FITC-RM4-5, Cat. No. 553047) and 0.25 µg of PE-conjugated rat anti-mouse IL-4 antibody (PE11B11, Cat. No 554435) by using the Pharmingen staining protocol (left panel). To demonstrate staining specificity, the binding of PE-11B11 was blocked by the preincubation of the conjugated antibody with excess recombinant mouse IL-4 (0.25 µg; Cat. No. 550067) (right panel) or by pre-blocking fixed/permeabilized cells with excess purified 11B11 mAb (5.0 µg; Cat. No. 554433) (data not shown), prior to staining. An approprate isotype control is PE-conjugated R3-34, (Cat. No. 554685). The quadrant markers for the bivariate dot plots were set based on the autofluorescence control, and verified using the cytokine-blocking or mAb blocking controls.
Expression of IL-4 by stimulated CD4+ and CD4-BALB/c spleen cells. BALB/c spleen cells were cultured for 72 h in medium containing Staphylococcus aureus enterotoxin B (2 µg/ml; Sigma, St. Louis, MO), recombinant mouse IL-2 (10 U/ml, Cat. No. 550069) and recombinant mouse IL-4 (2 ng/ml, Cat. No. 550067). The cells were harvested and restimulated for 5 h with anti-CD3 (145-2C11, Cat. No. 553057 at 2 µg/ml) and anti-CD28 (clone 37.51, Cat. No. 553294 at 2 µg/ml) antibodies in the presence of 3 µM monensin (BD GolgiStop, Cat No. 554704). The splenocytes were then stained with 0.25 µg of FITC-conjugated rat anti-mouse CD4 (FITC-RM4-5, Cat. No. 553047) and 0.25 µg of PE-conjugated rat anti-mouse IL-4 antibody (PE11B11, Cat. No 554435) by using the Pharmingen staining protocol (left panel). To demonstrate staining specificity, the binding of PE-11B11 was blocked by the preincubation of the conjugated antibody with excess recombinant mouse IL-4 (0.25 µg; Cat. No. 550067) (right panel) or by pre-blocking fixed/permeabilized cells with excess purified 11B11 mAb (5.0 µg; Cat. No. 554433) (data not shown), prior to staining. An approprate isotype control is PE-conjugated R3-34, (Cat. No. 554685). The quadrant markers for the bivariate dot plots were set based on the autofluorescence control, and verified using the cytokine-blocking or mAb blocking controls.
Expression of IL-4 by stimulated CD4+ and CD4-BALB/c spleen cells. BALB/c spleen cells were cultured for 72 h in medium containing Staphylococcus aureus enterotoxin B (2 µg/ml; Sigma, St. Louis, MO), recombinant mouse IL-2 (10 U/ml, Cat. No. 550069) and recombinant mouse IL-4 (2 ng/ml, Cat. No. 550067). The cells were harvested and restimulated for 5 h with anti-CD3 (145-2C11, Cat. No. 553057 at 2 µg/ml) and anti-CD28 (clone 37.51, Cat. No. 553294 at 2 µg/ml) antibodies in the presence of 3 µM monensin (BD GolgiStop, Cat No. 554704). The splenocytes were then stained with 0.25 µg of FITC-conjugated rat anti-mouse CD4 (FITC-RM4-5, Cat. No. 553047) and 0.25 µg of PE-conjugated rat anti-mouse IL-4 antibody (PE11B11, Cat. No 554435) by using the Pharmingen staining protocol (left panel). To demonstrate staining specificity, the binding of PE-11B11 was blocked by the preincubation of the conjugated antibody with excess recombinant mouse IL-4 (0.25 µg; Cat. No. 550067) (right panel) or by pre-blocking fixed/permeabilized cells with excess purified 11B11 mAb (5.0 µg; Cat. No. 554433) (data not shown), prior to staining. An approprate isotype control is PE-conjugated R3-34, (Cat. No. 554685). The quadrant markers for the bivariate dot plots were set based on the autofluorescence control, and verified using the cytokine-blocking or mAb blocking controls.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Flow Cytometry: The 11B11 antibody has been reported to be useful for the immunofluorescent staining and flow cytometric analysis of IL-4-producing cells. The PE-conjugated 11B11 antibody can be used for multicolor flow cytometric analyses to identify and enumerate IL-4 producing cells within mixed cell populations (see right image). For optimal immunofluorescent staining with flow cytometric analysis, this anti-cytokine antibody should be pretitrated (≤ 0.5 µg mAb/million cells). An approprate isotype control is PE-conjugated R3-34, (Cat. No. 554685). For specific methodology, please visit our web site, www.bdbiosciences.com, and go to the protocols section or the chapter on intracellular staining.
BD® CompBeads can be used as surrogates to assess fluorescence spillover (compensation). When fluorochrome conjugated antibodies are bound to BD® CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cell and BD® CompBeads to ensure that BD® CompBeads are appropriate for your specific cellular application.
Interleukin-4 (IL-4) is a pleiotropic cytokine that has many roles, such as inducing the differentiation of naïve helper T cells (Th0 cells) to Th2 cells, stimulating activated B-cell and T-cell proliferation, and promoting immunoglobulin class switching to IgG1 and IgE in mouse B-cells. IL-4 is expressed by CD4 T-cells, mast cells, basophils and eosinophils. IL-4 was previously known as B-Cell Differentiation Factor (BCDF) or B-cell Stimulatory Factor (BSF1). The 11B11 monoclonal antibody specifically binds to mouse IL-4. The immunogen used to generate the 11B11 hybridoma was partially purified mouse IL-4 prepared from the supernatant of Phorbol 12-Myristate 13-Acetate (PMA)-stimulated EL-4 cells. The 11B11 antibody is reportedly a neutralizing antibody.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.